Log In
BCIQ
Print this Print this
 

ABT-348

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionAurora kinase inhibitor
Molecular Target Aurora kinases
Mechanism of ActionAurora kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today